177 related articles for article (PubMed ID: 20144270)
1. The role of C1GALT1C1 in lipopolysaccharide-induced IgA1 aberrant O-glycosylation in IgA nephropathy.
Xie LS; Qin W; Fan JM; Huang J; Xie XS; Li Z
Clin Invest Med; 2010 Feb; 33(1):E5-13. PubMed ID: 20144270
[TBL] [Abstract][Full Text] [Related]
2. Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
He L; Peng Y; Liu H; Yin W; Chen X; Peng X; Shao J; Liu Y; Liu F
Am J Nephrol; 2013; 38(4):321-32. PubMed ID: 24107646
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolic acid reverses IgA1 aberrant glycosylation through up-regulating Cosmc expression in IgA nephropathy.
Xie L; Tan C; Fan J; Fu P; Tang Y; Tao Y; Qin W
Int Urol Nephrol; 2013 Apr; 45(2):571-9. PubMed ID: 23136028
[TBL] [Abstract][Full Text] [Related]
4. Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy.
Ji L; Chen X; Zhong X; Li Z; Yang L; Fan J; Tang W; Qin W
BMC Complement Altern Med; 2014 Jun; 14():195. PubMed ID: 24942185
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17 promotes the production of underglycosylated IgA1 in DAKIKI cells.
Lin JR; Wen J; Zhang H; Wang L; Gou FF; Yang M; Fan JM
Ren Fail; 2018 Nov; 40(1):60-67. PubMed ID: 29299950
[TBL] [Abstract][Full Text] [Related]
6. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
Wang C; Ye M; Zhao Q; Xia M; Liu D; He L; Chen G; Peng Y; Liu H
Am J Nephrol; 2019; 49(4):307-316. PubMed ID: 30917363
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy.
Sun Q; Zhang J; Zhou N; Liu X; Shen Y
PLoS One; 2015; 10(2):e0112305. PubMed ID: 25647400
[TBL] [Abstract][Full Text] [Related]
8. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
[TBL] [Abstract][Full Text] [Related]
9. C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy.
Xing Y; Li L; Zhang Y; Wang F; He D; Liu Y; Jia J; Yan T; Lin S
BMC Nephrol; 2020 Jan; 21(1):18. PubMed ID: 31941451
[TBL] [Abstract][Full Text] [Related]
10. External suppression causes the low expression of the Cosmc gene in IgA nephropathy.
Qin W; Zhong X; Fan JM; Zhang YJ; Liu XR; Ma XY
Nephrol Dial Transplant; 2008 May; 23(5):1608-14. PubMed ID: 18202089
[TBL] [Abstract][Full Text] [Related]
11. Increased miR-374b promotes cell proliferation and the production of aberrant glycosylated IgA1 in B cells of IgA nephropathy.
Hu S; Bao H; Xu X; Zhou X; Qin W; Zeng C; Liu Z
FEBS Lett; 2015 Dec; 589(24 Pt B):4019-25. PubMed ID: 26545495
[TBL] [Abstract][Full Text] [Related]
12. Capsaicin induces high expression of BAFF and aberrantly glycosylated IgA1 of tonsillar mononuclear cells in IgA nephropathy patients.
Shao J; Peng Y; He L; Liu H; Chen X; Peng X
Hum Immunol; 2014 Oct; 75(10):1034-9. PubMed ID: 25167771
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of core 1 beta1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1.
Yamada K; Kobayashi N; Ikeda T; Suzuki Y; Tsuge T; Horikoshi S; Emancipator SN; Tomino Y
Nephrol Dial Transplant; 2010 Dec; 25(12):3890-7. PubMed ID: 20551088
[TBL] [Abstract][Full Text] [Related]
14. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
15. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
Smith AC; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
[TBL] [Abstract][Full Text] [Related]
16. Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy.
Liu H; Peng Y; Liu F; Xiao W; Zhang Y; Li W
Inflamm Res; 2011 Sep; 60(9):869-78. PubMed ID: 21614556
[TBL] [Abstract][Full Text] [Related]
17. Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy.
Zhai YL; Zhu L; Shi SF; Liu LJ; Lv JC; Zhang H
Medicine (Baltimore); 2016 Mar; 95(11):e3099. PubMed ID: 26986150
[TBL] [Abstract][Full Text] [Related]
18. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
[TBL] [Abstract][Full Text] [Related]
19. Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.
Xie YX; He LY; Chen X; Peng XF; Ye MY; Zhao YJ; Yan WZ; Liu C; Shao J; Peng YM
Int Urol Nephrol; 2016 Nov; 48(11):1855-1861. PubMed ID: 27465795
[TBL] [Abstract][Full Text] [Related]
20. TGF-β1 mimics the effect of IL-4 on the glycosylation of IgA1 by downregulating core 1 β1, 3-galactosyltransferase and Cosmc.
Xiao J; Wang M; Xiong D; Wang Y; Li Q; Zhou J; Chen Q
Mol Med Rep; 2017 Feb; 15(2):969-974. PubMed ID: 28035353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
